These outcomes, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 support the idea of concentrating on ACKR3 as a novel way to modulate the opioid system, which could open new therapeutic avenues for opioid-related Problems.Take note: Final results may perhaps change abou